KELSEY COBB: Open Payments
NPI 1336534064 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 14 payments from 10 companies in 2025. Trend: 2023 $540 · 2024 $245 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Novo Nordisk Inc | 2 | $32 |
| Abbott Laboratories | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: MOUNJARO, LEQVIO, ETERNA, UBRELVY, YUPELRI, CAPLYTA, GEMTESA, EVENITY.
Industry payments across LA — which companies pay providers there.
